TAIPEI — Taiwan's Ministry of Health and Welfare and the National Health Insurance Administration on Monday released a comprehensive national roadmap for artificial intelligence integration across the island's public healthcare network, formalising an expansion that health officials have been signalling for several weeks. The plan outlines a three-phase deployment of AI-assisted diagnostic tools in radiology, oncology, and chronic disease management across all regional and district hospitals under the National Health Insurance system by the end of 2028.

The announcement coincides with Taiwan's annual push for observer status at the World Health Assembly, which convened in Geneva this month. Health Minister Chiu Tai-yuan framed the AI healthcare initiative as evidence of Taiwan's capacity to contribute meaningfully to global health governance, arguing that excluding the island of 23 million from WHO mechanisms leaves a data gap in pandemic surveillance and disease modelling. 'Taiwan's AI-driven health infrastructure is already among the most integrated in the Asia-Pacific region,' Chiu said at a Taipei press conference. 'We are ready to share this capability with the world, if the world allows us a seat at the table.'

The roadmap draws on partnerships with domestic technology firms including MediaTek and Acer's healthcare division, as well as collaboration agreements with academic medical centres in the United States and Japan. A pilot programme at National Taiwan University Hospital, which used AI tools to flag early-stage lung nodules in chest CT scans, was cited as the model for system-wide rollout. Officials said the programme reduced radiologist review time by approximately 30 percent during a 12-month trial period.

Analysts tracking health technology in the Asia-Pacific noted that the timing of the announcement is deliberate. 'Taiwan consistently uses the WHA window to demonstrate institutional readiness,' said Dr. Mei-Ling Huang, a health policy researcher at Academia Sinica. 'Publishing a concrete AI roadmap rather than a position paper is a more sophisticated diplomatic signal than in previous years.' China, which blocks Taiwan's formal participation in WHO bodies, has not yet responded to Monday's announcement.

The roadmap also addresses data governance, requiring that all patient data used to train or validate AI diagnostic models be anonymised under standards aligned with the EU's General Data Protection Regulation, a move intended to ease future interoperability with European health systems. Taiwan's health authorities said they would publish an open dataset from the NHI's 25-year claims database later in 2026, which researchers internationally have long regarded as one of the most complete population health records in the world.